Key statistics
On Monday, Bolt Biotherapeutics Inc (6LP:DUS) closed at 0.546, 9.31% above its 52-week low of 0.4995, set on Sep 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.541 |
---|---|
High | 0.546 |
Low | 0.523 |
Bid | 0.56 |
Offer | 0.590 |
Previous close | 0.540 |
Average volume | 748.57 |
---|---|
Shares outstanding | 38.26m |
Free float | 36.94m |
P/E (TTM) | -- |
Market cap | 22.14m USD |
EPS (TTM) | -1.71 USD |
Data delayed at least 15 minutes, as of Nov 25 2024 18:31 GMT.
More ▼
Announcements
- Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
- Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting
- Bolt Biotherapeutics Announces Changes to its Board of Directors
- Bolt Biotherapeutics to Participate in Upcoming September Conferences
- Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
- Bolt Biotherapeutics Reports First Quarter 2024 Results, Announces Strategic Pipeline Prioritization and Changes to Leadership Team
- Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
- Bolt Biotherapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
- Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu®
More ▼